Moderna’s share price popped in August on positive news about its therapeutic cancer vaccine to prevent melanoma from ...
The thing I’m most worried about right now is actually bioterrorism.” —Moderna CEO Stéphane Bancel, speaking about the risks ...
Phase 3 data for intismeran autogene in the adjuvant treatment of patients with resected stage IIB-IV melanoma selected ...
Moderna (NASDAQ:MRNA) executives emphasized the company’s evolution beyond COVID-19 vaccines during a discussion with ...
Wanderlust Travel Videos on MSN
Gardens by the Bays moderna glasarkitektur i Singapore (4K)
Den här vandringen utforskar Gardens by the Bay i Singapore med närbilder av de stora böjda glasbyggnaderna. Rutten lyfter ...
Moderna stock jumped 7% on Thursday, September 24, closing at $195 as investors kept betting on intismeran autogene’s Phase 3 melanoma data due at ESMO on October 24. Street Split: The 23 analysts ...
A coveted Presidential Symposium slot at Europe's top oncology congress just sent Moderna shares flying 9%, but the actual ...
Combinando practicidad, diseño progresivo y una excelente experiencia de conducción, Nissan presenta el nuevo Nissan PIXO, un ...
La escritora presentará su nueva novela el 5 de octubre en una cita literaria que cuenta con el apoyo de la firma fundada por ...
Ángel Cabrera, titular de la dependencia, dijo que ante la mayor adopción de la inteligencia artificial se espera que haya ...
Vozači sve češće žele da tokom jednog zaustavljanja završe više stvari: da natoče gorivo, popiju kafu, nešto pojedu, kupe ono ...
Moderna (MRNA) reached a 52-week high as CEO Bancel emphasized the company's mRNA platform capabilities beyond COVID vaccines, spotlighting cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results